Free Trial

Whitener Capital Management Inc. Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intuitive Surgical logo with Medical background

Whitener Capital Management Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 15.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,079 shares of the medical equipment provider's stock after buying an additional 808 shares during the quarter. Whitener Capital Management Inc.'s holdings in Intuitive Surgical were worth $3,011,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $25,000. Hurley Capital LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Chilton Capital Management LLC lifted its stake in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Finally, Global Financial Private Client LLC lifted its stake in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $13.99 during mid-day trading on Friday, reaching $512.06. 2,951,229 shares of the company were exchanged, compared to its average volume of 1,682,083. Intuitive Surgical, Inc. has a twelve month low of $413.82 and a twelve month high of $616.00. The firm's 50-day simple moving average is $537.85 and its two-hundred day simple moving average is $536.68. The firm has a market cap of $183.53 billion, a PE ratio of 75.08, a price-to-earnings-growth ratio of 5.43 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period last year, the firm earned $1.50 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Piper Sandler decreased their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Barclays dropped their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Finally, Royal Bank Of Canada decreased their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $592.59.

Read Our Latest Stock Analysis on Intuitive Surgical

Insiders Place Their Bets

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director directly owned 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president directly owned 5,224 shares of the company's stock, valued at $2,695,113.84. This represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock valued at $2,611,577 over the last 90 days. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines